| |
|
| |
The New Skin Cancer Stack
From AI detection and optical imaging to molecular diagnostics and personalized treatment.
Skin cancer may become one of the first areas of medicine where AI, imaging, diagnostics, and biotech converge across the entire patient journey.
Computer vision is getting better at identifying suspicious lesions. New imaging technologies are pushing beyond what the naked eye can see. Molecular diagnostics and biomarkers are adding another layer of information. And on the treatment side, precision therapies and personalized cancer vaccines are changing what happens after diagnosis.
But what does the future skin-cancer stack actually look like?
This conversation will bring together founders, clinicians, researchers, biotech leaders, and investors working across AI, dermatology, oncology, diagnostics, imaging, and therapeutics to explore:
- Where AI can genuinely change skin-cancer detection
- Whether non-invasive imaging can reduce unnecessary biopsies
- How molecular diagnostics and biomarkers fit alongside imaging
- What multimodal models could unlock when images, clinical history, pathology, and molecular data come together
- How personalized therapeutics are changing melanoma treatment
- Where the biggest unsolved opportunities still exist
Not another conversation about AI replacing doctors.
A discussion about what happens when the entire stackfrom detection to diagnosis to treatmentstarts getting rebuilt.
This event is a part of #SFTechWeeka week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com." data-next-head="
|
|
|
|
|
|
|
|
